These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26281943)

  • 1. Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes.
    Vergidis J; Gresham G; Lim HJ; Renouf DJ; Kennecke HF; Ruan JY; Chang JT; Cheung WY
    Clin Colorectal Cancer; 2016 Mar; 15(1):16-23. PubMed ID: 26281943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
    Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
    Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
    Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM
    Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better survival in right-sided versus left-sided stage I - III colon cancer patients.
    Warschkow R; Sulz MC; Marti L; Tarantino I; Schmied BM; Cerny T; Güller U
    BMC Cancer; 2016 Jul; 16():554. PubMed ID: 27464835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data Base.
    Gabriel E; Attwood K; Thirunavukarasu P; Al-Sukhni E; Boland P; Nurkin S
    J Am Coll Surg; 2016 Mar; 222(3):232-44. PubMed ID: 26922599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
    Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN
    BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
    Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
    JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
    J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.
    Hsu T; Speers CH; Kennecke HF; Cheung WY
    Cancer; 2017 May; 123(10):1839-1847. PubMed ID: 28081292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
    André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
    J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
    J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial.
    Dahdaleh FS; Sherman SK; Poli EC; Vigneswaran J; Polite BN; Sharma MR; Catenacci DV; Maron SB; Turaga KK
    Surgery; 2018 Dec; 164(6):1223-1229. PubMed ID: 30297240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of screening colonoscopy on outcomes in colon cancer surgery.
    Amri R; Bordeianou LG; Sylla P; Berger DL
    JAMA Surg; 2013 Aug; 148(8):747-54. PubMed ID: 23784448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity is an independent prognostic variable in colon cancer survivors.
    Sinicrope FA; Foster NR; Sargent DJ; O'Connell MJ; Rankin C
    Clin Cancer Res; 2010 Mar; 16(6):1884-93. PubMed ID: 20215553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.